p62在银屑病样疾病中的性别特异性抗炎作用
本研究在可诱导表皮失活c-Jun和JunB的小鼠模型(DKO*)中评估p62对银屑病样皮肤及全身表型的功能作用。DKO*与p62-/-小鼠杂交后,雄性DKO* p62-/-小鼠出现皮肤和关节疾病加重,表皮增厚、角质形成细胞分化紊乱、免疫细胞浸润增强及CXCL1表达增加仅见于雄性小鼠皮肤。雄性小鼠皮肤中雄激素受体蛋白表达及信号激活增强、炎症小体和KEAP1/NRF2活性上调,可能参与疾病恶化。
要点
- p62在银屑病样疾病中发挥性别特异性的抗炎作用,雄性小鼠缺失p62后皮肤和关节病变加重。
- 雄性DKO* p62-/-小鼠皮肤中雄激素受体信号、炎症小体和KEAP1/NRF2活性上调,可能是恶化机制。
- 该性别特异性机制可能对银屑病临床治疗策略具有参考意义。
核心结论
- p62在银屑病样疾病中具有性别特异性的抗炎作用,雄性小鼠缺失p62导致皮肤和关节疾病加重。
研究设计与样本
- 研究采用可诱导表皮失活c-Jun和JunB的小鼠模型(DKO*),并与p62-/-小鼠杂交(DKO* p62-/-)进行功能评估。
主要发现
- 雄性DKO* p62-/-小鼠出现皮肤和关节疾病加重。
- 表皮增厚、角质形成细胞分化紊乱、免疫细胞浸润增强及CXCL1表达增加仅见于雄性DKO* p62-/-小鼠皮肤。
- 雄性DKO* p62-/-小鼠皮肤中雄激素受体蛋白表达及信号激活增强,炎症小体和KEAP1/NRF2活性上调。
临床怎么用
- 该发现提示p62相关通路及雄激素受体信号可能成为银屑病性别特异性治疗策略的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic inflammatory skin disease involving a complex cross-talk between immune and epidermal cells. Psoriasis is difficult to treat and often complicated by systemic manifestations such as psoriatic arthritis. SQSTM1/p62 is a multifunctional adaptor protein controlling autophagy, cell differentiation, and inflammation that was found elevated in human psoriatic skin. We functionally evaluated the role of p62 in the cutaneous and systemic psoriasis-like phenotypes of a mouse model with inducible epidermal inactivation of c-Jun and JunB (ie, DKO∗). A male-specific aggravation of skin and joint disease was observed in DKO∗ mice when crossed with p62-/- mice (DKO∗ p62-/-). Thickened epidermis, disturbed keratinocyte differentiation, enhanced immune cell infiltration, and increased CXCL1 expression were exclusively observed in the skin of male DKO∗ p62-/- mice. Increased androgen receptor protein expression and activation of androgen receptor signaling as well as upregulated inflammasome and KEAP1/NRF2 activities were apparent in the skin of male DKO∗ p62-/- mice and were likely responsible for disease worsening. Our results describe a sex-specific anti-inflammatory role for p62 in psoriasis-like disease that could be relevant in the clinical setting.
引用
- Mieczkowski K, Bakiri L, Griss J, et al. A Sex-Specific Anti-Inflammatory Role for p62 in Psoriasis-Like Disease. J Invest Dermatol. 2025. PMID: 40258471. doi:10.1016/j.jid.2025.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。